BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35022893)

  • 1. Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use.
    Acheampong T; Lee Argov EJ; Terry MB; Rodriguez CB; Agovino M; Wei Y; Athilat S; Tehranifar P
    Cancer Causes Control; 2022 Mar; 33(3):363-371. PubMed ID: 35022893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density.
    Lee Argov EJ; Acheampong T; Terry MB; Rodriguez CB; Agovino M; Wei Y; Athilat S; Tehranifar P
    Breast Cancer Res; 2020 Sep; 22(1):99. PubMed ID: 32933550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication use and mammographic breast density.
    Han Y; Lee CT; Xu S; Mi X; Phillip CR; Salazar AS; Rakhmankulova M; Toriola AT
    Breast Cancer Res Treat; 2021 Sep; 189(2):585-592. PubMed ID: 34196899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of metformin and aspirin intake with mammographic breast density: A cross-sectional study.
    Eslami B; Omranipour R; Arian A; Bayani L; Abedi M; Alipour S
    Caspian J Intern Med; 2023; 14(4):741-745. PubMed ID: 38024179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of aspirin and other anti-inflammatory medications with mammographic breast density and breast cancer risk.
    Yaghjyan L; Wijayabahu A; Eliassen AH; Colditz G; Rosner B; Tamimi RM
    Cancer Causes Control; 2020 Sep; 31(9):827-837. PubMed ID: 32476101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of statin use on volumetric mammographic density: results from the KARMA study.
    Skarping I; Brand JS; Hall P; Borgquist S
    BMC Cancer; 2015 May; 15():435. PubMed ID: 26016855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breastfeeding and Mammographic Breast Density: A Cross-sectional Study.
    Getz KR; Adedokun B; Xu S; Toriola AT
    Cancer Prev Res (Phila); 2023 Jun; 16(6):353-361. PubMed ID: 36930943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of age at menarche and adult height with mammographic density in the International Consortium of Mammographic Density.
    Ward SV; Burton A; Tamimi RM; Pereira A; Garmendia ML; Pollan M; Boyd N; Dos-Santos-Silva I; Maskarinec G; Perez-Gomez B; Vachon C; Miao H; Lajous M; López-Ridaura R; Bertrand K; Kwong A; Ursin G; Lee E; Ma H; Vinnicombe S; Moss S; Allen S; Ndumia R; Vinayak S; Teo SH; Mariapun S; Peplonska B; Bukowska-Damska A; Nagata C; Hopper J; Giles G; Ozmen V; Aribal ME; Schüz J; Van Gils CH; Wanders JOP; Sirous R; Sirous M; Hipwell J; Kim J; Lee JW; Dickens C; Hartman M; Chia KS; Scott C; Chiarelli AM; Linton L; Flugelman AA; Salem D; Kamal R; McCormack V; Stone J
    Breast Cancer Res; 2022 Jul; 24(1):49. PubMed ID: 35836268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin use is associated with lower mammographic density in a large screening cohort.
    Wood ME; Sprague BL; Oustimov A; Synnstvedt MB; Cuke M; Conant EF; Kontos D
    Breast Cancer Res Treat; 2017 Apr; 162(3):419-425. PubMed ID: 28160159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational diabetes, type II diabetes, and mammographic breast density in a U.S. racially diverse population screened for breast cancer.
    Oskar S; Engmann NJ; Azus AR; Tehranifar P
    Cancer Causes Control; 2018 Aug; 29(8):731-736. PubMed ID: 29948515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between mammographic density measures and aspirin or other NSAID use.
    Stone J; Willenberg L; Apicella C; Treloar S; Hopper J
    Breast Cancer Res Treat; 2012 Feb; 132(1):259-66. PubMed ID: 22037829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mammographic density among women with a strong family history of breast cancer.
    Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
    BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of change in body mass index on volumetric measures of mammographic density.
    Hart V; Reeves KW; Sturgeon SR; Reich NG; Sievert LL; Kerlikowske K; Ma L; Shepherd J; Tice JA; Mahmoudzadeh AP; Malkov S; Sprague BL
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1724-30. PubMed ID: 26315554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density and markers of socioeconomic status: a cross-sectional study.
    Aitken Z; Walker K; Stegeman BH; Wark PA; Moss SM; McCormack VA; Silva Idos S
    BMC Cancer; 2010 Feb; 10():35. PubMed ID: 20144221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign breast disease and changes in mammographic breast density.
    Reimers LL; Goldberg M; Tehranifar P; Michels KB; Cohn BA; Flom JD; Wei Y; Cirillo P; Terry MB
    Breast Cancer Res; 2021 Apr; 23(1):49. PubMed ID: 33902651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect of aspirin on mammographic density in a randomized controlled clinical trial.
    McTiernan A; Wang CY; Sorensen B; Xiao L; Buist DS; Aiello Bowles EJ; White E; Rossing MA; Potter J; Urban N
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1524-30. PubMed ID: 19423529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors.
    Yaghjyan L; Colditz GA; Rosner B; Tamimi RM
    Breast Cancer Res Treat; 2015 Feb; 150(1):181-9. PubMed ID: 25677739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN).
    Butler LM; Gold EB; Greendale GA; Crandall CJ; Modugno F; Oestreicher N; Quesenberry CP; Habel LA
    Breast Cancer Res Treat; 2008 Nov; 112(1):165-74. PubMed ID: 18066689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk.
    Nguyen TL; Aung YK; Evans CF; Dite GS; Stone J; MacInnis RJ; Dowty JG; Bickerstaffe A; Aujard K; Rommens JM; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Apicella C; Hopper JL
    Int J Epidemiol; 2017 Apr; 46(2):652-661. PubMed ID: 28338721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case-control study.
    Velásquez García HA; Sobolev BG; Gotay CC; Wilson CM; Lohrisch CA; Lai AS; Aronson KJ; Spinelli JJ
    Breast Cancer Res Treat; 2018 Jul; 170(1):159-168. PubMed ID: 29516373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.